U.S. Stock News

In late October 2025, United States Antimony Corporation announced the restart of its Montana Stibnite Hill mine after 40 years and revealed a new five-year, US$245 million contract as the sole antimony supplier to the U.S. Defense Logistics Agency. The company described the mine restart as a "game changer," which enables a significant revenue guidance increase, expansion projects, and supply chain security amid heightened demand for domestic critical minerals. We'll explore how the Pentagon...

Bread Financial Holdings, Inc. recently completed a US$500 million offering of 6.750% senior notes due 2031 to help redeem its higher-cost 9.750% senior notes due 2029, marking a significant corporate refinancing move with participation from multiple co-lead underwriters. This refinancing initiative is expected to improve the company’s capital structure and enhance future financial flexibility by replacing more expensive debt with lower-cost notes. We’ll examine how replacing higher-cost...

Cencora, Inc. recently announced its full-year results for the period ended September 30, 2025, reporting US$321.33 billion in sales and net income of US$1.55 billion, but also disclosed a fourth-quarter net loss of US$339.7 million mainly due to very large goodwill impairment charges related to PharmaLex. Despite the quarterly loss, the company raised its quarterly dividend by 9% to US$0.60 per share, signaling confidence in its long-term financial outlook. To understand Cencora’s future...

In the past week, V2X Inc announced record third quarter results with revenue of US$1.17 billion and net income of US$24.61 million, supported by significant contract wins and the completion of a specialized intelligence acquisition. The company raised its 2025 revenue guidance and finalized a US$10 million share repurchase, reflecting growing demand and operational progress in the defense sector. V2X's enhanced contract pipeline, now standing at US$50 billion, and recent major award wins...

News (NWSA) shares moved in Thursday's session, catching some attention after a minor uptick. Market participants appear to be weighing recent price action and short-term trends, especially given uncertainty in the broader media sector. See our latest analysis for News. News shares have seen some short-term bumps, but momentum has generally faded since the start of the year. The 1-year total shareholder return of -8.8% reflects modest losses. Even so, those who bought and held over a longer...

Enterprise Financial Services (EFSC) just released third quarter earnings, showing net interest income climbing to $158 million while net income dipped from last year. The company also declared new dividends on both preferred and common shares. See our latest analysis for Enterprise Financial Services. Enterprise Financial Services has seen some ups and downs this year, with its latest third quarter report and fresh dividend declarations sparking renewed investor attention. After a tougher...

Targa Resources (TRGP) has seen some movement in its stock price over the past week, gaining around 12%. This recent performance has put the company on many investors’ radar. In the past month, the stock is up about 2%. See our latest analysis for Targa Resources. Targa Resources has enjoyed a burst of momentum lately, with its 7-day share price return of nearly 12% catching the attention of investors. Despite some ups and downs over the past year, the stock’s 3-year total shareholder return...

Chord Energy Corporation recently announced its third quarter 2025 financial results, reporting a decrease in both revenue and net income year-on-year, along with updated production guidance for the fourth quarter and full year. The simultaneous affirmation of its dividend and completion of a significant share repurchase underlines management's continued focus on shareholder returns amid operational headwinds. We'll explore how Chord Energy's weaker-than-expected earnings and revised...

Boston Scientific (BSX) reported strong third-quarter 2025 financial results, with its Electrophysiology division seeing remarkable growth due to the FARAPULSE Pulsed Field Ablation System and expanded FDA approval. Product launches and strategic moves also contributed to this momentum. See our latest analysis for Boston Scientific. Boston Scientific’s recent product launches and surging Electrophysiology sales have helped maintain momentum in what is becoming a more competitive space, even...

In late October 2025, Medtronic announced new three-year clinical results at the TCT conference showing its Symplicity Spyral renal denervation system significantly reduced blood pressure without major safety issues compared to the control group. The reported absence of serious long-term side effects, such as renal artery stenosis, strengthens the commercial and regulatory outlook for this hypertension device in nearly 80 global markets. We’ll examine how these long-term clinical outcomes...

Parsons Corporation recently reported third-quarter 2025 earnings, showing sales of US$1.62 billion and net income of US$64.12 million, while also revising its full-year revenue guidance downward to US$6.40–6.50 billion. Despite lower revenues, the company secured new contracts exceeding US$100 million in the Middle East and completed an acquisition to strengthen its position in water infrastructure and technology-enabled services. We'll examine how the mix of lowered revenue expectations...

Marathon Petroleum (MPC) reported a sharp jump in net income and earnings per share for the third quarter, even as sales edged down compared to last year. This earnings beat is catching investors’ attention. See our latest analysis for Marathon Petroleum. Marathon Petroleum’s stock has gained significant momentum this year, with a year-to-date share price return of nearly 37% and an impressive 1-year total shareholder return of 29%. Big moves like the $650 million buyback and recent boardroom...

In early November 2025, Centrus Energy Corp. completed a follow-on equity offering totaling over US$196 million, filed for an additional US$1 billion at-the-market equity offering, and registered a diverse range of securities under a universal shelf registration, following the announcement of strong third quarter earnings results. This combination of significant capital-raising moves immediately after robust financial performance suggests Centrus is focused on expanding its funding...

Thinking about whether Main Street Capital is trading at a fair price? You're not alone. Questions about whether the stock is a value play or getting ahead of itself are top of mind for many investors right now. In the past year, Main Street Capital's stock delivered a 21.6% return, even though short-term moves have been mixed, with a 3.1% rise in the last week but a -3.1% dip over the past month. These moves come as market sentiment shifts after recent announcements about Main Street...

The New York Times Company recently reported strong third quarter 2025 results, with revenue rising to US$700.82 million from US$640.18 million a year earlier and net income increasing to US$81.65 million from US$64.14 million. These earnings reflect significant year-over-year growth and underline the company’s robust performance in both revenue and profitability for the period ending September 30, 2025. We’ll examine how this robust quarterly earnings result affects New York Times’ outlook...

SiteOne Landscape Supply, Inc. recently announced third quarter 2025 earnings, reporting sales of US$1.26 billion and net income of US$59.1 million, both higher than the prior year, along with a positive outlook for modest organic sales growth in the upcoming quarter. An interesting detail is that while strong operational gains were achieved, no shares were repurchased by the company during the latest period, signaling a focus on reinvestment over capital return. We'll explore how SiteOne's...

On November 4, 2025, Knife River Corporation released its third-quarter results, reporting quarterly revenue of US$1.20 billion and net income of US$143.2 million, alongside tightening its full-year 2025 guidance to revenue between US$3.10 billion and US$3.15 billion, and net income between US$140 million and US$160.5 million. An important development was Wells Fargo's upgrade of Knife River, highlighting optimism for a recovery in Oregon due to recent legislative advances in transportation...

Earlier this week, Domino's Pizza reached a new 52-week low as the company reported strong Q3 earnings but signaled slowing sales momentum and weaker consumer sentiment heading into Q4 2025. This turn of events comes as Domino's pursues long-term growth through technology integration and store expansion while contending with declining net income and shifting consumer preferences. We'll explore how concerns about weakening consumer sentiment could alter Domino's long-term investment case and...

Conagra Brands recently reported first-quarter 2026 revenue and adjusted earnings that exceeded expectations, reaffirming its annual forecasts despite inflation and tariff challenges. This update underscores the company’s confidence in managing cost pressures through pricing actions and efficiency initiatives while facing persistent macroeconomic headwinds. We will examine how Conagra’s better-than-expected quarterly results and cost management approach influence its long-term investment...

Teva Pharmaceutical Industries recently reported third-quarter 2025 results, showing a return to profitability with net income of US$433 million on sales of US$4.48 billion, and provided updated revenue guidance for 2025 and long-term sales targets. Institutional investment increased, highlighted by Phoenix Financial’s large share purchase, as Teva continued to execute its turnaround plan and expand efforts in branded medicines and biosimilars. Against this backdrop, we'll consider how...

VNET Group recently issued China's first holding-type real estate green asset-backed security under its new private REIT project, transferring 100% equity of a premium retail IDC project to the REIT with 93% subscribed by institutional investors and 7% retained by VNET. This milestone transaction positions VNET as a leader in sustainable asset management in the data center industry while allowing it to recycle capital and reduce leverage for future growth and capacity expansion. Let's...

Curious whether Organon stock is an attractive opportunity or a value trap? Let’s take a look beneath the surface to help you decide if this is a hidden gem or something best left alone. After a sharp drop of 33.8% over the past month and a year-to-date slide of 54.7%, it is clear that investor sentiment and market risk perceptions for Organon have shifted dramatically. News of ongoing legal actions around women’s health products, as well as recent reports on the company's efforts to manage...

Terns Pharmaceuticals (TERN) is making headlines after its investigational drug, TERN-701, delivered a high major molecular response rate at 24 weeks for chronic myeloid leukemia patients. This result has impressed experts and driven analyst upgrades. See our latest analysis for Terns Pharmaceuticals. Terns Pharmaceuticals' shares have rocketed this year, with a 225.75% year-to-date share price return and a staggering 203.78% jump over the past 90 days, driven by strong TERN-701 trial data...

Scorpio Tankers (STNG) revealed a new round of fleet changes this week, agreeing to sell four older MR product tankers and acquire four newbuilds for delivery through 2027. This is a clear step toward renewing its fleet and boosting operational efficiency. See our latest analysis for Scorpio Tankers. Scorpio Tankers has seen its 30-day share price return jump 18.2%, while its 1-year total shareholder return sits at 21.4%. This comes after news of fleet expansion and a fresh quarterly...